Sarah Larney1, Kate Dolan. 1. Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, N.S.W., Australia. s.larney@unsw.edu.au
Abstract
BACKGROUND/AIMS: Opioid substitution treatment (OST) is an effective treatment for heroin dependence. The World Health Organization has recommended that OST be implemented in prisons because of its role in reducing drug injection and associated problems such as HIV transmission. The aim of this paper was to examine the extent to which OST has been implemented in prisons internationally. METHODS: Literature review. RESULTS: As of January 2008, OST had been implemented in prisons in at least 29 countries or territories. For 20 of those countries, the proportion of all prisoners in OST could be calculated, with results ranging from less than 1% to over 14%. At least 37 countries offer OST in community settings, but not prisons. CONCLUSION: This study has identified an increase in the international implementation of OST in prisons. However, there remain large numbers of prisoners who are unable to access OST, even in countries that provide such programs. This raises issues of equivalence of care for prisoners and HIV prevention in prisons. 2009 S. Karger AG, Basel.
BACKGROUND/AIMS: Opioid substitution treatment (OST) is an effective treatment for heroin dependence. The World Health Organization has recommended that OST be implemented in prisons because of its role in reducing drug injection and associated problems such as HIV transmission. The aim of this paper was to examine the extent to which OST has been implemented in prisons internationally. METHODS: Literature review. RESULTS: As of January 2008, OST had been implemented in prisons in at least 29 countries or territories. For 20 of those countries, the proportion of all prisoners in OST could be calculated, with results ranging from less than 1% to over 14%. At least 37 countries offer OST in community settings, but not prisons. CONCLUSION: This study has identified an increase in the international implementation of OST in prisons. However, there remain large numbers of prisoners who are unable to access OST, even in countries that provide such programs. This raises issues of equivalence of care for prisoners and HIV prevention in prisons. 2009 S. Karger AG, Basel.
Authors: Alexander R Bazazi; Jeffrey A Wickersham; Martin P Wegman; Gabriel J Culbert; Veena Pillai; Roman Shrestha; Haider Al-Darraji; Michael M Copenhaver; Adeeba Kamarulzaman; Frederick L Altice Journal: Contemp Clin Trials Date: 2017-05-04 Impact factor: 2.226
Authors: Jeffrey A Wickersham; Muhammad Muhsin Zahari; Marwan M Azar; Adeeba Kamarulzaman; Frederick L Altice Journal: Drug Alcohol Depend Date: 2013-02-13 Impact factor: 4.492
Authors: Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland Journal: Lancet Date: 2010-07-31 Impact factor: 79.321
Authors: Kate Dolan; Suzy Teutsch; Nicolas Scheuer; Michael Levy; William Rawlinson; John Kaldor; Andrew Lloyd; Paul Haber Journal: Eur J Epidemiol Date: 2010-02 Impact factor: 8.082
Authors: Sarah Larney; Hannah Kopinski; Curt G Beckwith; Nickolas D Zaller; Don Des Jarlais; Holly Hagan; Josiah D Rich; Brenda J van den Bergh; Louisa Degenhardt Journal: Hepatology Date: 2013-08-06 Impact factor: 17.425